Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-12-009002
Filing Date
2012-03-01
Accepted
2012-03-01 18:13:04
Documents
1
Period of Report
2012-02-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 5622
  Complete submission text file 0001127602-12-009002.txt   7037
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 200 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 200 WESTMINSTER CO 80020 3034266262
ALLOS THERAPEUTICS INC (Issuer) CIK: 0001097264 (see all company filings)

EIN.: 541655029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALLOS THERAPEUTICS, INC. 11080 CIRCLEPOINT ROAD, SUITE 200 WESTMINSTER CO 80020
Business Address
Morris Charles Q (Reporting) CIK: 0001489966 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29815 | Film No.: 12659441